Pfizer licensing exec
Pfizer promotesVP-Worldwide Regulatory Affairs & Quality Assurance Edmund Harrigan to senior VP-worldwide licensing & business development, the company announces Oct. 13. As head of the newly created group, Harrigan will be responsible for co-promotion and licensing agreements, VC investments in new technologies and the acquisition of external products and services. The group "brings together previously separate functions so that all the capabilities and resources necessary to evaluate and secure these opportunities are in one place, with a clear strategy and accountability," Pfizer says...
You may also be interested in...
Pink Sheet reporters and editor discuss President-Elect Joe Biden’s decision to name the CDER director as acting FDA commissioner and other staffing changes, as well as changes to industry trade groups’ political donations.
Delfi Diagnostics will use the new funds to expand its team of cancer researchers and machine-learning experts to validate its novel approach for early cancer detection through multiple prospective clinical trials.
US Ninth Circuit affirms a district court’s summary judgment in favor of Target and manufacturer of Up & Up brand biotin supplement it sells. Indian manufacturer targeted in putative class-action in New York prompted FDA’s 2016 creation of import alert category for Ayurvedic supplements.